03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Clariscan : | |
Type | Medicine-Like |
Originator | B |
Agent | Droguerie de l'Union |
Distributor | Droguerie de l'Union |
Laboratory | GE HealthCare |
Manufacturer | GE HealthCare |
Origin | Norway |
ATC | V08CA02 |
Clariscan :
Clariscan :
Clariscan :
Clariscan :
Clariscan :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Clariscan :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Very rare |
Agitation | Very rare |
Anaphylactic reactions | Uncommon |
Anaphylactoid reactions | Uncommon |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
Anxiety | Very rare |
Arrhythmia | Very rare |
Asthenia | Very rare |
Back pain | Very rare |
Bradycardia | Very rare |
Bronchospasm | Very rare |
Cardiac arrest | Very rare |
Chest discomfort | Very rare |
Chest pain | Very rare |
Chills | Very rare |
Coma | Very rare |
Conjunctivitis | Very rare |
Convulsion | Very rare |
Cough | Very rare |
Diarrhoea (Diarrhea) | Very rare |
Dizziness | Very rare |
Dry throat | Very rare |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Rare |
Dyspnoea (dyspnea) | Very rare |
Eczema | Very rare |
Erythema | Common |
Eyelid oedema | Very rare |
Face oedema | Very rare |
Feeling cold | Common |
Feeling hot | Common |
Fever | Very rare |
Headache | Very Common |
Hyperhidrosis | Rare |
Hypersensitivity | Uncommon |
Hypertension | Very rare |
Hypotension | Very rare |
Injection site discomfort | Very rare |
Injection site extravasation | Very rare |
Injection site inflammation | Very rare |
Injection site oedema | Very rare |
Injection site pain | Common |
Injection site reaction | Very rare |
Lacrimation increased (Epiphora) | Very rare |
Laryngospasm | Very rare |
Malaise | Very rare |
Muscle contracture | Very rare |
Muscle weakness | Very rare |
Nasal congestion | Very rare |
Nausea | Common |
Nephrogenic systemic fibrosis | Not known |
Ocular hyperaemia | Very rare |
Oxygen saturation decreased | Very rare |
Pallor | Very rare |
Palpitations | Very rare |
Paraesthesia (paresthesia) | Very Common |
Parosmia | Very rare |
Pharyngeal oedema | Very rare |
Presyncope | Very rare |
Pruritus | Common |
Pulmonary oedema | Very rare |
Respiratory arrest | Very rare |
Salivary hypersecretion | Very rare |
Skin rash | Common |
Sneezing | Very rare |
Syncope | Very rare |
Tachycardia | Very rare |
Tremor | Very rare |
Urticaria | Rare |
Vasodilation | Very rare |
Vision blurred | Very rare |
Vomiting | Common |
Different Units By MoH Code
Clariscan MoH 2065494 :
Form | Solution for injection |
Packaging | Vial (Type I Glass) |
Package Size | 1x10ml |
Strength | 0.5mmol/ml |
Storage Condition | <30°C None |
Stratum | N/A |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | N/A |
Price Comparison
You have to register to view this info
Clariscan MoH 2065493 :
Form | Solution for injection |
Packaging | Vial (Type I Glass) |
Package Size | 1x20ml |
Strength | 0.5mmol/ml |
Storage Condition | <30°C None |
Stratum | N/A |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | N/A |
Price Comparison
You have to register to view this info
Clariscan MoH 2065492 :
Form | Solution for injection |
Packaging | Vial (Type I Glass) |
Package Size | 1x15ml |
Strength | 0.5mmol/ml |
Storage Condition | <30°C None |
Stratum | N/A |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | N/A |
Price Comparison
You have to register to view this info
Drop File